• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏疾病中的表观遗传学

Epigenetics in liver disease.

作者信息

Mann Derek A

机构信息

Fibrosis Research Laboratories, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.

出版信息

Hepatology. 2014 Oct;60(4):1418-25. doi: 10.1002/hep.27131. Epub 2014 May 7.

DOI:10.1002/hep.27131
PMID:24633972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4258082/
Abstract

UNLABELLED

Epigenetics is a term that encompasses a variety of regulatory processes that are able to crosstalk in order to influence gene expression and cell phenotype in response to environmental cues. A deep understanding of epigenetics offers the potential for fresh insights into the basis for complex chronic diseases and improved diagnostic and prognostic tools. Moreover, as epigenetic modifications are highly plastic and responsive to the environment, there is much excitement around the theme of epigenetic therapeutics, including not only new drugs but also more informed patient advice on lifestyle choices and their impact on pathology. This review briefly explains the molecular nature of the individual regulatory process that constitute epigenetics, including DNA methylation, histone modifications, chromatin remodeling, transcriptional control, and noncoding RNAs. The ways in which these epigenetic mechanisms influence liver physiology and disease will be considered in detail, particularly in the context of cancer, fibrosis, and nonalcoholic steatohepatitis. The current limitations associated with epigenetic profiling and therapeutics in liver disease are discussed, as is the intriguing possibility that environmental-induced epigenetic changes may become stable and heritable.

CONCLUSION

The aim of the review is to inform hepatologists of the emerging key epigenetic ideas of relevance to liver diseases that are highly likely to form a component of patient management and care in the next decade.

摘要

未标注

表观遗传学是一个涵盖多种调控过程的术语,这些调控过程能够相互作用,以响应环境线索影响基因表达和细胞表型。深入了解表观遗传学有望为复杂慢性疾病的发病基础提供新的见解,并改进诊断和预后工具。此外,由于表观遗传修饰具有高度可塑性且对环境有反应,围绕表观遗传治疗的主题有很多令人兴奋的地方,这不仅包括新药,还包括关于生活方式选择及其对病理影响的更明智的患者建议。本综述简要解释了构成表观遗传学的各个调控过程的分子本质,包括DNA甲基化、组蛋白修饰、染色质重塑、转录调控和非编码RNA。将详细探讨这些表观遗传机制影响肝脏生理和疾病的方式,特别是在癌症、纤维化和非酒精性脂肪性肝炎的背景下。讨论了目前与肝脏疾病表观遗传分析和治疗相关的局限性,以及环境诱导的表观遗传变化可能变得稳定且可遗传的有趣可能性。

结论

本综述的目的是让肝病学家了解与肝脏疾病相关的新兴关键表观遗传学观点,这些观点极有可能在未来十年成为患者管理和护理的一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9a/4258082/6e814be49bdb/hep0060-1418-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9a/4258082/dd144d522b2f/hep0060-1418-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9a/4258082/6e814be49bdb/hep0060-1418-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9a/4258082/dd144d522b2f/hep0060-1418-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9a/4258082/6e814be49bdb/hep0060-1418-f2.jpg

相似文献

1
Epigenetics in liver disease.肝脏疾病中的表观遗传学
Hepatology. 2014 Oct;60(4):1418-25. doi: 10.1002/hep.27131. Epub 2014 May 7.
2
Epigenomics in stress tolerance of plants under the climate change.植物在气候变化下的应激耐受中的表观基因组学。
Mol Biol Rep. 2023 Jul;50(7):6201-6216. doi: 10.1007/s11033-023-08539-6. Epub 2023 Jun 9.
3
Epigenetics in liver disease: from biology to therapeutics.肝病中的表观遗传学:从生物学到治疗学
Gut. 2016 Nov;65(11):1895-1905. doi: 10.1136/gutjnl-2015-311292. Epub 2016 Sep 13.
4
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease.代谢相关脂肪性肝病的表观遗传药物发现全景。
Trends Genet. 2020 Jun;36(6):429-441. doi: 10.1016/j.tig.2020.03.003. Epub 2020 Mar 28.
5
Epigenomes in Cardiovascular Disease.心血管疾病中的表观基因组学。
Circ Res. 2018 May 25;122(11):1586-1607. doi: 10.1161/CIRCRESAHA.118.311597.
6
Investigation of epigenetics in kidney cell biology.肾细胞生物学中的表观遗传学研究。
Methods Cell Biol. 2019;153:255-278. doi: 10.1016/bs.mcb.2019.04.015. Epub 2019 Jun 13.
7
The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism.表观遗传修饰对肝脏疾病发生发展的影响及其作用机制。
Expert Rev Gastroenterol Hepatol. 2020 Apr;14(4):259-270. doi: 10.1080/17474124.2020.1736042. Epub 2020 Mar 3.
8
Epigenetic modifications as new targets for liver disease therapies.表观遗传修饰作为肝脏疾病治疗的新靶点。
J Hepatol. 2013 Dec;59(6):1349-53. doi: 10.1016/j.jhep.2013.05.039. Epub 2013 Jun 4.
9
The emerging role of epigenetics in rheumatic diseases.表观遗传学在风湿性疾病中的新兴作用。
Rheumatology (Oxford). 2014 Mar;53(3):406-14. doi: 10.1093/rheumatology/ket292. Epub 2013 Sep 11.
10
Epigenetic regulation of liver fibrosis.肝纤维化的表观遗传调控
Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S64-8. doi: 10.1016/j.clinre.2015.05.013. Epub 2015 Jul 16.

引用本文的文献

1
Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease.营养素作为代谢功能障碍相关脂肪性肝病中的表观遗传调节剂。
World J Hepatol. 2025 Aug 27;17(8):108182. doi: 10.4254/wjh.v17.i8.108182.
2
Naringin and Naringenin in Liver Health: A Review of Molecular and Epigenetic Mechanisms and Emerging Therapeutic Strategies.柚皮苷和柚皮素对肝脏健康的影响:分子和表观遗传机制及新兴治疗策略综述
Antioxidants (Basel). 2025 Aug 10;14(8):979. doi: 10.3390/antiox14080979.
3
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.

本文引用的文献

1
Clinical Toxicities of Histone Deacetylase Inhibitors.组蛋白去乙酰化酶抑制剂的临床毒性
Pharmaceuticals (Basel). 2010 Aug 26;3(9):2751-2767. doi: 10.3390/ph3092751.
2
DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery.非酒精性脂肪性肝病的 DNA 甲基化分析表明,减肥手术后存在独特的疾病特异性和重塑特征。
Cell Metab. 2013 Aug 6;18(2):296-302. doi: 10.1016/j.cmet.2013.07.004.
3
Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.
组蛋白去乙酰化酶抑制剂罗米地辛使肝癌易受受体酪氨酸激酶靶向作用影响且具有免疫活性。
Nat Commun. 2025 Aug 25;16(1):7919. doi: 10.1038/s41467-025-62934-0.
4
Mapping DNA methylation to cardiac pathologies induced by beta-adrenergic stimulation in a large panel of mice.在大量小鼠中,将DNA甲基化与β-肾上腺素能刺激诱导的心脏病变进行关联分析。
Epigenetics. 2025 Dec;20(1):2524411. doi: 10.1080/15592294.2025.2524411. Epub 2025 Jul 7.
5
Mapping DNA Methylation to Cardiac Pathologies Induced by Beta-Adrenergic Stimulation in a Large Panel of Mice.在大量小鼠中绘制DNA甲基化与β-肾上腺素能刺激诱导的心脏病理之间的关系。
bioRxiv. 2024 Oct 26:2024.10.25.619688. doi: 10.1101/2024.10.25.619688.
6
LncRNA aggravates hepatic steatosis via PPARγ signaling.长链非编码 RNA 通过过氧化物酶体增殖物激活受体 γ 信号加重肝脂肪变性。
Elife. 2024 Oct 22;13:RP96988. doi: 10.7554/eLife.96988.
7
A new opportunity for N-acetylcysteine. An outline of its classic antioxidant effects and its pharmacological potential as an epigenetic modulator in liver diseases treatment.N-乙酰半胱氨酸的新机遇。概述其经典抗氧化作用及其作为表观遗传调节剂在肝病治疗中的药理潜力。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2365-2386. doi: 10.1007/s00210-024-03539-0. Epub 2024 Oct 22.
8
A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact.丙型肝炎病毒相关肝细胞癌的遗传学和表观遗传学文献综述:转化影响
Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):650-661. doi: 10.21037/hbsn-23-562. Epub 2024 Apr 18.
9
Advances in liquid biopsy in neuroblastoma.神经母细胞瘤液体活检的进展
Fundam Res. 2022 Aug 17;2(6):903-917. doi: 10.1016/j.fmre.2022.08.005. eCollection 2022 Nov.
10
Liver epigenomic signature associated with chronic oxidative stress in a mouse model of glutathione deficiency.与谷胱甘肽缺乏症小鼠模型中慢性氧化应激相关的肝脏表观基因组特征。
Chem Biol Interact. 2024 Aug 1;398:111093. doi: 10.1016/j.cbi.2024.111093. Epub 2024 Jun 1.
非酒精性脂肪性肝病患者的甲基组学与转录组学之间的关系。
Gastroenterology. 2013 Nov;145(5):1076-87. doi: 10.1053/j.gastro.2013.07.047. Epub 2013 Jul 31.
4
DNA methylation contributes to natural human variation.DNA 甲基化有助于自然的人类变异。
Genome Res. 2013 Sep;23(9):1363-72. doi: 10.1101/gr.154187.112. Epub 2013 Aug 1.
5
Identification of driver genes in hepatocellular carcinoma by exome sequencing.外显子组测序鉴定肝细胞癌的驱动基因。
Hepatology. 2013 Nov;58(5):1693-702. doi: 10.1002/hep.26540. Epub 2013 Sep 24.
6
Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.肝癌细胞中过氧化物酶体增殖物激活受体γ和乙型肝炎病毒 X 蛋白对 microRNA-122 的表观遗传调控。
Hepatology. 2013 Nov;58(5):1681-92. doi: 10.1002/hep.26514. Epub 2013 Sep 17.
7
Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.阐明肝细胞癌中异常 DNA 甲基化的全景。
PLoS One. 2013;8(2):e55761. doi: 10.1371/journal.pone.0055761. Epub 2013 Feb 20.
8
Transgenerational effects of prenatal exposure to the 1944-45 Dutch famine.胎儿期暴露于 1944-1945 年荷兰饥荒的跨代效应。
BJOG. 2013 Apr;120(5):548-53. doi: 10.1111/1471-0528.12136. Epub 2013 Jan 24.
9
DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis.DNA 甲基化和 MeCP2 对大鼠肝纤维化中 PTCH1 表达的调控。
Cell Signal. 2013 May;25(5):1202-11. doi: 10.1016/j.cellsig.2013.01.005. Epub 2013 Jan 16.
10
A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job.一种治疗肝纤维化的新策略:让 MicroRNAs 来完成这项工作。
BioDrugs. 2013 Feb;27(1):25-34. doi: 10.1007/s40259-012-0005-2.